Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the SB 137 topic
No spam. Unsubscribe anytime.
Committee rejects bill that would expand insurer coverage for maxillofacial procedures
Summary
A Senate committee declined to advance SB 137, which would have clarified insurer coverage for maxillofacial services arising from congenital anomalies, disease or trauma after testimony from prosthodontists and objections citing broad language and contested fiscal estimates.
The Senate Insurance & Commerce Committee did not advance Senate Bill 137 after a contested hearing in which proponents urged the panel to clarify coverage for maxillofacial services and opponents warned the measure would be broader than intended.
Grant Fortson, representing Arkansas surgical prosthodontists, told the committee SB 137 would clarify that certain maxillofacial services — those incidental to craniofacial anomalies, disease or trauma and necessary to restore speech, swallowing or chewing, or to control infection and pain — are covered. Dr. Dean McNeal, a dentist with decades of clinical experience, described work with craniofacial teams and tumor boards and said recent denials by carriers have left patients without needed reconstructive care.
An opponent who did not identify himself in the transcript argued the bill would open coverage to routine dental services and cited an actuarial estimate of $7–$9 million in added costs. Sponsors and proponents pushed back that the measure is limited to medically necessary services tied to craniofacial conditions and that an established craniofacial review process and existing protocols would remain relevant. After debate and public comment the sponsor did not secure a second or sufficient support and the chair recorded that the bill did not pass.
The committee’s discussion highlighted disagreement over scope and fiscal risk; the record shows no roll‑call vote and no floor referral for SB 137.
